Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank80
3Y CAGR+75.6%
5Y CAGR+125.2%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+75.6%/yr
Annual compound
5Y CAGR
+125.2%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
58x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $170.58M | -11.3% |
| 2024 | $192.40M | +127.3% |
| 2023 | $84.66M | +168.9% |
| 2022 | $31.48M | +68.1% |
| 2021 | $18.73M | +536.3% |
| 2020 | $2.94M | - |